全球伤寒抗体检测市场规模、份额、趋势和成长分析报告（2026-2034年）

预计伤寒抗体检测市场将从 2025 年的 17.9 亿美元成长到 2034 年的 49.2 亿美元，2026 年至 2034 年的复合年增长率为 11.89%。

受发展中国家伤寒发生率上升的推动，全球伤寒抗体检测市场正稳定成长。准确快速的诊断检测对于适当的治疗和疾病管理至关重要。人们对感染疾病预防意识的提高也促进了市场成长。

关键成长要素包括快速诊断试剂盒和检查室免疫检测的进步。促进早期发现的公共卫生措施和免疫接种计划正在推动市场需求。农村地区医疗保健服务的普及也促进了检测率的提高。此外，政府对感染疾病监测的支持也在推动市场扩张。

展望未来，检测灵敏度的提高和照护现场解决方案的广泛应用预计将对市场产生积极影响。新兴经济体对医疗基础设施的投资将创造新的机会。各公司正致力于开发经济高效且易于使用的检测套组。鑑于感染疾病监测的重要性依然不变，全球伤寒抗体检测市场预计将稳定成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球伤寒抗体检测市场：按类型划分

• 市场分析、洞察与预测
• 血清学检测
• 核酸增幅检查
• 聚合酵素链锁反应检测

第五章 全球伤寒抗体检测市场：依技术划分

• 市场分析、洞察与预测
• 酵素免疫分析法（ELISA）
• 快速诊断测试
• 蛋白质印迹法

第六章 全球伤寒抗体检测市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 参考测试机构
• 诊断中心
• 家庭测试

第七章 全球伤寒抗体检测市场：依样本类型划分

• 市场分析、洞察与预测
• 血液样本
• 血清样本
• 血浆样本

第八章：全球伤寒抗体检测市场：依应用领域划分

• 市场分析、洞察与预测
• 临床诊断
• 研究与开发
• 流行病学研究

第九章 全球伤寒抗体检测市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十一章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories
  • BioRad Laboratories
  • Diagnostic BioSystems
  • Hoffmann-La Roche
  • Hycult Biotech
  • Medmix
  • Zhejiang Dian Diagnostics
  • VivaDiag
  • Roche Holding
  • Siemens Healthineers
  • Grifols
  • Meridian Bioscience
  • Wako Pure Chemical Industries
  • Thermo Fisher Scientific
  • Adaltis

The Typhoid Antibody Testing Market size is expected to reach USD 4.92 Billion in 2034 from USD 1.79 Billion (2025) growing at a CAGR of 11.89% during 2026-2034.

The Global Typhoid Antibody Testing Market is growing steadily due to rising incidence of typhoid fever in developing regions. Accurate and rapid diagnostic testing is essential for timely treatment and disease control. Increasing awareness about infectious disease prevention is supporting market growth.

Key growth drivers include advancements in rapid diagnostic kits and laboratory-based immunoassays. Public health initiatives promoting early detection and vaccination programs are strengthening demand. Expanding healthcare access in rural areas is also contributing to higher testing rates. Additionally, government support for infectious disease surveillance is supporting market expansion.

Looking ahead, the market is expected to benefit from improved test sensitivity and point-of-care solutions. Emerging economies investing in healthcare infrastructure will present new opportunities. Companies are focusing on cost-effective and easy-to-use testing kits. As infectious disease monitoring remains critical, the Global Typhoid Antibody Testing Market is projected to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Serologic Tests
• Nucleic Acid Amplification Tests
• Polymerase Chain Reaction Tests

By Technology

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Rapid Diagnostic Tests
• Western Blotting

By End User

• Hospitals
• Reference Laboratories
• Diagnostic Centers
• Homecare Testing

By Sample Type

• Blood Samples
• Serum Samples
• Plasma Samples

By Application

• Clinical Diagnosis
• Research and Development
• Epidemiological Studies

COMPANIES PROFILED

• Abbott Laboratories, BioRad Laboratories, Diagnostic BioSystems, HoffmannLa Roche, Hycult Biotech, Medmix, Zhejiang Dian Diagnostics, VivaDiag, Roche Holding, Siemens Healthineers, Grifols, Meridian Bioscience, Wako Pure Chemical Industries, Thermo Fisher Scientific, Adaltis
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Serologic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Nucleic Acid Amplification Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Polymerase Chain Reaction Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Enzyme-Linked Immunosorbent Assay (ELISA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Rapid Diagnostic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Western Blotting Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Reference Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Homecare Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Sample Type
• 7.2. Blood Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Serum Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Plasma Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Clinical Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Research and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Epidemiological Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Type
  • 9.2.2 By Technology
  • 9.2.3 By End User
  • 9.2.4 By Sample Type
  • 9.2.5 By Application
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Type
  • 9.3.2 By Technology
  • 9.3.3 By End User
  • 9.3.4 By Sample Type
  • 9.3.5 By Application
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Type
  • 9.4.2 By Technology
  • 9.4.3 By End User
  • 9.4.4 By Sample Type
  • 9.4.5 By Application
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Type
  • 9.5.2 By Technology
  • 9.5.3 By End User
  • 9.5.4 By Sample Type
  • 9.5.5 By Application
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Type
  • 9.6.2 By Technology
  • 9.6.3 By End User
  • 9.6.4 By Sample Type
  • 9.6.5 By Application
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL TYPHOID ANTIBODY TESTING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott Laboratories
  • 11.2.2 BioRad Laboratories
  • 11.2.3 Diagnostic BioSystems
  • 11.2.4 Hoffmann-La Roche
  • 11.2.5 Hycult Biotech
  • 11.2.6 Medmix
  • 11.2.7 Zhejiang Dian Diagnostics
  • 11.2.8 VivaDiag
  • 11.2.9 Roche Holding
  • 11.2.10 Siemens Healthineers
  • 11.2.11 Grifols
  • 11.2.12 Meridian Bioscience
  • 11.2.13 Wako Pure Chemical Industries
  • 11.2.14 Thermo Fisher Scientific
  • 11.2.15 Adaltis